Keryx Biopharmaceuticals has announced that the FDA has approved Ferric Citrate (formerly known as Zerenex) for the control of serum...
Rockwell Medical announced successful topline results from the PRIME clinical study of Soluble Ferric Pyrophosphate (SFP), its investigational iron-delivery drug...
Keryx Biopharmaceuticals announced the publication of results from its pivotal Phase III study evaluating Auryxia/Fexeric (ferric citrate) for iron deficiency...
Keryx Biopharmaceuticals announced that the European Commission has approved Fexeric (ferric citrate coordination complex) for the control of elevated serum...
Shield Therapeutics plc notes the recent publication in the journal Inflammatory Bowel Diseases of positive long-term results from a AEGIS-H2H study comparing the effectiveness of ferric maltol 30 mg bid (Feraccru/Accrufer) with intravenous (IV) iron (ferric carboxymaltose given according to each centre’s standard practice) over 52 weeks.